Indication
Bulimia nervosa
4 clinical trials
3 products
1 drug
Clinical trial
A Double-Blind Placebo-Controlled Evaluation of Effectiveness of Oral Naltrexone in Management of Adolescent Eating DisordersStatus: Terminated, Estimated PCD: 2024-05-21
Product
NaltrexoneClinical trial
Development of a Pharmacodynamic Biomarker of Opioid Antagonism in Adolescents With Eating DisordersStatus: Recruiting, Estimated PCD: 2026-09-01
Drug
VarlilumabClinical trial
Acipimox Administration Together With Short-Term Exercise Exerts A Co-Feedback of Growth Hormone, Pancreatic Polypeptide, Peptide YY and Leptin on Ghrelin in Young Bulimic Czech Women: A Randomized StudyStatus: , Estimated PCD: 2007-12-16
Product
AcipimoxClinical trial
Multimodal Longitudinal and Machine Learning-based Predictive Modelling to Understand the Development of Eating DisordersStatus: Recruiting, Estimated PCD: 2024-12-01
Product
Blood and urine samples